
Universal Health ServicesUHS
Quality and valuation
How Universal Health Services compares with other health care stocks. A description, not a recommendation.
LLY
JNJ
ABBV
MRK
UNH
UHSUniversal Health Services and 5 health care facilities peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
An average business among health care companies, priced below most of them.
Universal Health Services trades at 7.9 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew faster than the sector median: +10.0% vs +7.8%
- Less profitable (operating margin): 11.4% vs 13.3%
- Turns less of its sales into cash: 4.7% vs 15.9%
Financials
From Universal Health Services's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.
| Last 12 months | UHS | Sector median |
|---|---|---|
| Revenue growth | +10.0% | +7.8% |
| Operating margin | 11.4% | 13.3% |
| Free cash flow margin | 4.7% | 15.9% |
| Price to earnings | 7.4x | 30.2x |
Stories on Universal Health Services
We haven't written about Universal Health Services yet. Follow it, and its first story will show under My stocks on the front page.
Similar companies
Health Care Facilities, by market value.
| Company | Price | Today |
|---|---|---|
LLYEli Lilly | $1,417.54 | +3.19% |
JNJJohnson & Johnson | $273.20 | −0.73% |
ABBVAbbVie | $294.89 | +1.41% |
MRKMerck | $149.52 | +2.18% |
UNHUnitedHealth | $406.97 | −0.96% |
NVSNovartis | $160.79 | −0.19% |
AZNAstraZeneca | $186.65 | +7.02% |
TMOThermo Fisher Scientific | $697.00 | −1.72% |


